Glaucoma

Neuroprotection in glaucoma: drug-based approaches
In recent years the focus of glaucoma research has shifted toward neuroprotection, as the traditional strategies of lowering intraocular pressure have been shown to be unable to prevent progressive vision loss in some glaucoma patients.

London, UK
UK
Topical and oral ketorolac administration increases the intraocular pressure-lowering effect of lata
PURPOSE: To verify the influence of a non-steroidal anti-inflammatory drug (NSAID), ketorolac (topical and oral) on the intraocular pressure reduction induced by 0.005% latanoprost topical administration, both in patients affected by primary open-angle glaucoma and in healthy controls.

Campobasso, Italy
Italy
[Surgery of primary open angle glaucoma.]
The selection of the surgical approach to glaucoma depends primarily on the type of glaucoma.


Germany
Quality of Diurnal IOP Control in Primary Open Angle Patients Treated with Latanoprost Compared to S
PURPOSE: To compare the IOP diurnal fluctuations of glaucoma patients treated with latanoprost 0.005% once a day to patients with controlled IOP after deep sclerectomy or trabeculectomy.


Switzerland
The efficacy and harm of prostaglandin analogues for IOP reduction in glaucoma patients compared to
AIM: To systematically review the literature on the efficacy and harm of prostaglandin analogues (PGAs) compared to brimonidine and dorzolamide in treating elevated intraocular pressure (IOP).
501 Smyth Road, Tower III
Ontario, Canada
Canada
The effects of dorzolamide 2% and dorzolamide/timolol fixed combination on retinal and optic nerve h
Purpose: To compare the effect of dorzolamide hydrochloride 2%, timolol maleate 0.5%, and their fixed combination on intraocular pressure (IOP) and retinal and optic nerve head haemodynamics in primary open-angle glaucoma patients.

Torino, Italy
Italy
[Intermediate-term outcome of glaucoma drainage devices.]
OBJECTIVE: To study the intermediate-term results of glaucoma drainage devices (DDG) with respect to control of intraocular pressure (IOP), control of glaucoma, and maintenance of pre-operative visual acuity.

Madrid, Spain
Spain
Comparison of the 24-hour intraocular pressure-lowering effects of latanoprost and dorzolamide/timol
PURPOSE: To evaluate the 24-hour intraocular pressure (IOP)-lowering effect of latanoprost and the dorzolamide/timolol fixed combination (DTFC) after 2 and 6 months of treatment.

Thessaloniki, Greece
Greece